Elizabeth Pan
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- Cancer Genomics and Diagnostics 6
- MicroRNA in disease regulation 4
-
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 3
- Co-authors
- Julie Teruya‐FeldsteinFerenc ReinhardtRobert A. WeinbergLi MaFrank SpelemanJennifer J. YoungFrank WestermannHarsha Prabhala
- Journals
- Journal of Clinical Oncology (4 papers)Molecular Cancer Therapeutics (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Cancer (1 paper)The Prostate (1 paper)
- Partner nations
- United StatesAustraliaBelgium
In The Last Decade
Elizabeth Pan
21 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 1.4k
- Molecular Biology 1.5k
- Oncology 331
- Pulmonary and Respiratory Medicine 150
- Neurology 55
Countries citing papers authored by Elizabeth Pan
This map shows the geographic impact of Elizabeth Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Pan more than expected).
Fields of papers citing papers by Elizabeth Pan
This network shows the impact of papers produced by Elizabeth Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Pan. The network helps show where Elizabeth Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Elizabeth Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 29 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 24 | |
| 11 | 2018 | 4 | |
| 12 | 2018 | 4 | |
| 13 | 2018 | 4 | |
| 14 | 2017 | 26 | |
| 15 | 2017 | 3 | |
| 16 | 2014 | 28 | |
| 17 | Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model | 2010 | 33 |
| 18 | miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | 2010 | 1 |
| 19 | Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Hit paper breakdown → | 2010 | 608 |
| 20 | miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Hit paper breakdown → | 2010 | 1108 |
About Elizabeth Pan
Elizabeth Pan is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Infectious Diseases and Emergency Medicine, having authored 24 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Prostate Cancer Treatment and Research (5 papers), MicroRNA in disease regulation (4 papers), Renal cell carcinoma treatment (3 papers), PARP inhibition in cancer therapy (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (1.5k citations), Oncology (331 citations), Pulmonary and Respiratory Medicine (150 citations) and Neurology (55 citations). Elizabeth Pan has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Julie Teruya‐Feldstein, Ferenc Reinhardt, Robert A. Weinberg, Li Ma, Frank Speleman, Jennifer J. Young, Frank Westermann, Harsha Prabhala, Pieter Mestdagh and Jo Vandesompele. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, International Journal of Radiation Oncology*Biology*Physics, Cancer and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.